Transcription Factor STOX1A Promotes Mitotic Entry by Binding to the CCNB1 Promotor by Abel, D. van et al.
Transcription Factor STOX1A Promotes Mitotic Entry by
Binding to the CCNB1 Promotor
Daan van Abel, Omar Abdul-Hamid, Marie van Dijk, Cees B. M. Oudejans*
Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
Abstract
Background: In this study we investigated the involvement of the transcription factor STOX1A in the regulation of the cell
cycle.
Methodology/Principal Findings: We found that several major cell cycle regulatory genes were differentially expressed
upon STOX1A stimulation and knockdown in the neuroblastoma cell line SH-SY5Y. This includes STOX1A dependent
differential regulation of cyclin B1 expression, a cyclin which is known to regulate mitotic entry during the cell cycle. The
differential regulation of cyclin B1 expression by STOX1A is direct as shown with chromatin immunoprecipitation. Results
furthermore suggest that mitotic entry is enhanced through the direct upregulation of cyclin B1 expression effectuated by
STOX1A.
Conclusions: In conclusion we hereby show that STOX1A is directly involved in the regulation of the cell cycle.
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Introduction
Mammalian cell division is controlled by the expression of cyclins
and activation of their associated cyclin dependent kinases (CDKs).
While the CDK components are generally expressed ubiquitously
during the cell cycle, expression of cyclins accumulate periodically
during distinct phases (G1, S, G2 and M phase) of the cell cycle [1].
In each phase, binding of cyclins with their corresponding CDK
forms an active cyclin/CDK complex. In general, G1 to S phase
progression is controlled by CDK2 bound to S-phase cyclins [2] (E-
and A-type) whereas G2 to M phase is triggered by CDK1
associated withmitotic cyclins [3] (A- and B-type). Active cyclin/cdk
complexes can phosphorylate several substrates, which subsequently
trigger cell cycle progression [4–6]. Many of these cyclin/cdk
complex substrates and regulators of the cell cycle machinery itself
have been characterized in detail, and recently it was shown to
include a group of proteins belonging to the forkhead transcription
factors. These transcription factors are characterized by a 100
amino acid DNA-binding motif termed the winged helix domain
[7–10]. Several studies have confirmed the role of forkhead
transcription factors in regulating the transcription of cell cycle
regulatory genes during the cell cycle [8–10]. Additionally, it has
been shown that multiple members of the forkhead transcription
factors are regulated by components of the cell cycle itself. These
include FOXM1 [8], FOXO1 [9] and FOXK2 [10].
Recently, Storkhead box 1A (STOX1A), a transcription factor
structurally and functionally related to the forkhead family of
transcription factors [11,12], has been shown to be expressed
abundantly in the brain and found to be upregulated in advanced
stages of Late Onset Alzheimer Disease (LOAD, Braak 3–6).
Secondly, STOX1A was found to be expressed at the centrosomes
of dividing cells [13]. Centrosomes serve as reaction centres for
several key regulators of the cell cycle machinery [14,15], where in
particular G2 to M-phase transition is triggered by cyclin B1-
CDK1 [16,17]. Together with the increasing evidence that
neurons, generally in a non-dividing state called G0, re-express a
multitude of cell-cycle regulators in Alzheimer’s disease (AD) [18–
20], let us to explore the involvement of STOX1A in cell cycle
related events. Here we show that in the neuroblastoma SH-SY5Y
cell line STOX1A directly regulates the expression of the mitotic
cyclin B1. Hereby we show that STOX1A, in addition to other
members of the forkhead transcription factors, is directly involved
in regulating the cell cycle. Upregulated expression of STOX1A in
LOAD therefore potentially influences neuronal cell cycle re-
entry.
Results
Expression analysis of SH-SY5Y cells stably transfected
with STOX1A during distinct phases of the cell cycle
To identify the expression pattern of STOX1A in stably
transfected SH-SY5Y cells we performed immunofluorescence
using an antibody against the Halotag attached to the STOX1A
recombinant protein. During interphase we observed primarily
nuclear and to a lesser extend cytoplasmic STOX1A staining
(Fig. 1A) which confirms the model of STOX1A nucleo-
cytoplasmic shuttling as previously described by our lab [12].
Nuclear localization represents the active form of STOX1A.
To investigate the expression pattern of STOX1A during
mitosis, cells were arrested at the G2/M-phase boundary. As also
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29769
observed for the forkhead transcription factor FOXK2 [10],
STOX1A shows a non-overlapping immunofluorescence pattern
with DNA (STOX1A-halotag/DAPI merge) shortly after nuclear
envelope breakdown in prometaphase. The non-overlapping
immunofluorescence pattern is best seen during metaphase and
anaphase until cytokinesis occurs when STOX1A immunofluo-
rescence overlaps with DNA (DAPI) (Fig. 1B). As shown previously
by us [15], STOX1A is concentrated at the centrosomes during
metaphase (Fig. 1B, white arrows).
STOX1A regulates cell proliferation in SH-SY5Y cells
As the results above indicate that STOX1A is involved in
mitosis, the effect of STOX1A on cell proliferation was tested by
using STOX1A siRNA knockdown in comparison to scrambled
siRNAs in the neuroblastoma SH-SY5Y cell line. Knockdown of
STOX1A resulted in a significant reduction of cell proliferation
compared to the scrambled siRNA control (Fig. 2A). In parallel, at
each time point, the amount of death cells were counted. However
we did not found significant differences in cell death between
STOX1A siRNA or scrambled siRNA transfected cells (Fig. 2A,
left graph). In concordance with the reduction in cell proliferation
upon STOX1A siRNA transfection, cells that were stably
transfected with STOX1A showed a significant increase in cell
proliferation compared to empty vector (MOCK) transfected SH-
SY5Y cells (Fig. 2B). In parallel, at each time point, the amount of
death cells were counted. No significant differences in cell death
between STOX1A and MOCK transfected cells were found
(Fig. 2B, left graph). Knockdown and stable overexpression of
STOX1A in the SH-SY5Y cell-line was confirmed at the mRNA
(Fig. 2C) and protein level (Fig. 2D).
Figure 1. Expression analysis of STOX1A in stably transfected SH-SY5Y cells. (A) Immunofluorescence shows exclusively nuclear or
cytoplasmic (white arrows) staining for STOX1A-Halotag protein in STOX1A stably transfected SH-SY5Y cells. (B) Cells undergoing mitosis showing a
non-overlapping STOX1A/DAPI immunofluorescence pattern during metaphase and anaphase until cytokinesis when STOX1A immunofluoresence
overlaps with DAPI (DNA) immunofluorescence.
doi:10.1371/journal.pone.0029769.g001
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Reduced cell proliferation by STOX1A siRNA knockdown and
increased cell proliferation by STOX1A overexpression suggest
STOX1A dependent cell cycle regulation. To test this we
measured mRNA levels of four major mammalian cell cycle
regulatory genes; cyclin A2 (CCNA2, involved in the S to G2
phase and G2 to M phase progression [21]), cyclin B1 (CCNB1,
involved in G2 to M phase progression [4]), cyclin C (CCNC,
involved in G0 to G1 phase progression [22]) and cyclin E1
(CCNE1, involved in G1 to S phase progression [23]). In stably
STOX1A transfected cells we found that CCNA2 and CCNB1
mRNA levels were significantly increased. CCNC mRNA levels
were significantly downregulated but no significant differences in
mRNA levels were seen for CCNE1 compared to stably MOCK
transfected cells (Fig. 3A). STOX1A siRNA knockdown resulted in
significantly decreased mRNA levels of CCNA2, CCNB1 and
CCNE1 and significantly upregulated CCNC mRNA levels
compared to scrambled controls (Fig. 3B). Since CCNB1 is the
cyclin involved in mitosis, CCNB1 reduction upon STOX1A
knockdown was also confirmed on westernblot. The CCNB1
associated kinase CDK1 showed reduced activity upon reduced
CCNB1 protein levels as measured on westernblot using an
antibody specifically recognizing the active form of CDK1
(Fig. 3C). In contrast, comparable protein levels of total CDK1
were found (Fig. 3C).
Figure 2. The effect of STOX1A on cell proliferation in the neuroblastoma cell-line SH-SY5Y. (A) The proliferation curve shows
significantly decreased cell proliferation for STOX1A siRNA transfected SH-SY5Y cells compared to scrambled controls after 1, 2, and 3 days in culture.
(A. left bar) In parallel we did not found significant differences in cell death between STOX1A siRNA and scrambled siRNA transfected cells at each of
the indicated time points. (B) The proliferation curve shows significantly increased cell proliferation for STOX1A compared to MOCK stably transfected
SH-SY5Y cells after 1, 2, and 3 days in culture. (B. left bar) In parallel we did not found significant differences in cell death between STOX1A and MOCK
transfected cells at each of the indicated time points. Bars are mean 6 SEM. P-values for each timepoint were calculated using two-tailed unpaired t-
test. (C) Overexpression and knockdown of STOX1A was determined with quantitative RT-PCR showing a mean 21 fold (mean DDCt 4.4) increase in
mRNA expression for STOX1A in stably transfected SH-SH5Y cells compared to the controls (Left bar) and a mean 71 fold (mean DDCt 6.15) decreased
mRNA expression for STOX1A siRNA transfected SH-SY5Y cells compared to the scrambled controls (right bar). Bars are mean 6 SEM. *** indicate
P,0.001 (one sample t-test with theoretical mean 0). N = 4, each sample was measured in triplicate. (D, Bottom left graph) Quantification of STOX1A-
Halotag protein was performed using densitometry. The ratio number of obtained band intensities for STOX1A (at the expected band size of 150 Kd)
divided by actin was compared to the ratio number of obtained band intensities for MOCK divided by actin for 3 independent experiments. A
significant increase for the STOX1A ratio number was found compared to the MOCK ratio number. (D, Bottom right graph) Quantification of
endogenous STOX1A protein was performed using densitometry. The ratio number of obtained band intensities for STOX1A siRNA (at the expected
band size of 110 Kd) divided by actin was compared to the ratio number of obtained band intensities for scrambled siRNA divided by actin for 3
independent experiments. A significant increase for the STOX1A siRNA ratio number was found compared to the scrambled siRNA ratio number. P-
values were calculated using two-tailed unpaired t-test, error bars represent 6 SEM, * indicate P,0.05, *** indicate P,0.001. Westernblot images are
a representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0029769.g002
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STOX1A directly regulates expression of CCNB1 thereby
enhancing progression into mitosis
Given the importance of CCNB1 at the G2/M-phase boundary
[6], and our results showing CCNB1 expression to be affected
by both knockdown and overexpression of STOX1A we
tested if STOX1A could also be directly involved in the regulation
of CCNB1 through binding to its promotor region. Therefore we
performed chromatin immunoprecipitation (ChIP). The 59 up-
stream regulatory region of the CCNB1 gene [24,25] (Fig. 4A) was
tested for enrichment in STOX1A ChIP DNA compared to the
Figure 3. STOX1A induces changes in several major cell cycle regulatory genes. (A) The effect of stable STOX1A overexpression in the SH-
SY5Y neuroblastoma cell line on four major mammalian cell cycle regulatory genes was determined with quantitative RT-PCR showing a mean 1,4
fold (mean DDCt is 20,49) and mean 1,72 fold (mean DDCt is 20,78) increased mRNA expression for CCNA2 and CCNB1, respectively, and a mean
1,22 fold (mean DDCt is 20,29) decreased mRNA expression for CCNC in STOX1A stably transfected cell compared to their negative controls. (B) The
effect of STOX1A knockdown in the SH-SY5Y neuroblastoma cell line on four major mammalian cell cycle regulatory genes was determined with
quantitative RT-PCR showing a mean 11,8 fold (mean DDCt is 23,56), mean 10.3 fold (mean DDCt is 23,37) and mean 3,8 fold (mean DDCt is 21,92)
increased mRNA expression for CCNA2, CCNB1 and CCNE1 respectively, and a mean 1,7 fold (mean DDCt is 20,77) increased mRNA expression for
CCNC in STOX1A siRNA treated cells compared to their negative controls. (A,B) Bars are mean 6 SEM. * indicate P,0.05, ** indicate P,0.01,
*** indicate P,0.001 (one sample t-test with theoretical mean 0). N = 4, each sample was measured in triplicate. (C) Expression of endogenous CCNB1
protein and the active form of the CDK1 protein was determined by western blot using total cell protein extracts obtained from STOX1A siRNA and
control treated SH-SY5Y cells. CCNB1 proteins were detected by a specific antibody recognizing total CCNB1 protein. CDK1 proteins were detected
using an antibody detecting total CDK1 protein levels and a specific antibody recognizing the active form of CDK1 phosphorylated at threonine 161.
An antibody specific for actin was used as a loading control. Westernblot image is a representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0029769.g003
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negative control in unsynchronized stably STOX1A transfected
SH-SY5Y cells. Because STOX1A expression analysis shows a non-
overlapping STOX1A immunofluorescence-DNA (DAPI) pattern
at specific phases during mitosis we speculated that a direct
interaction of STOX1A with the 59 upstream regulatory region of
the CCNB1 gene is like most transcription factors transiently lost
during mitosis. Therefore, in parallel, we also tested enrichment of
the 59 upstream regulatory region of the CCNB1 gene [24,25] in
stably STOX1A transfected SH-SY5Y cells arrested at the G2/M-
phase boundary. We found significant enrichment for the 59
upstream regulatory region of the CCNB1 gene [24,25] in
STOX1A ChIP DNA compared to their negative controls in
unsynchronized stably STOX1A transfected SH-SY5Y cells and
cells synchronized at the G2/M-phase boundary (Fig. 4B).
Furthermore, enrichment for the 59 upstream regulatory region of
CCNB1 in the unsynchronized cells (Fig. 4B, left bar) was compared
with cells synchronized at the G2/M-phase boundary (Fig. 4B, right
bar). As expected, cells that were harvested directly after a G2/M-
phase block showed a significantly lower enrichment for the 59
upstream regulatory region of the CCNB1 gene compared to cells
that were growing asynchronously (Fig. 4B).
To see if the direct regulation of STOX1A on CCNB1
expression would influence transition into the G2/M-phase
boundary we synchronized STOX1A and MOCK stably
transfected cells in the early S phase with thymidine. 0, 4 and
8 hours after thymidine release CCNB1 protein expression levels
were significantly higher in STOX1A compared to MOCK
transfected cells (Fig. 5). Furthermore, western blot analysis also
showed significantly higher protein expression of the mitosis
marker phospho-histone H3 (ser 10) in STOX1A compared to the
MOCK transfected cells at these timepoints (Fig. 5).
Discussion
Here we show, in addition to other members of the forkhead
transcription factors, that STOX1A is directly involved in
controlling the cell cycle via CCNB1. CCNB1 expression is
directly regulated via STOX1A by binding to a region previously
characterized as the 59 upstream regulatory region of the CCNB1
gene [24,25]. While CCNB1 is known to be a key regulator for
mitotic entry [26], the direct up-regulation of CCNB1 by
STOX1A let us to speculate if this would have an effect on this
phase of the cell cycle. Indeed, in stably STOX1A transfected SH-
SY5Y cells that were released from an S-phase block an earlier
appearance of the specific mitosis marker PhosH3 (ser10) in
parallel with higher CCNB1 protein levels was found. These
results show that STOX1A transfected cells progress more rapidly
into mitosis compared to control transfected cells. The finding that
knockdown of STOX1A causes a decrease in CCNB1 protein
levels and that the activity of CDK1 is also dramatically reduced
elucidates a role for STOX1A in mitotic entry.
Enrichment of the 59 upstream regulatory region of the CCNB1
gene in STOX1A transfected SH-SY5Y cells growing asynchro-
nously was significantly higher than in cells synchronized at the
G2/M-phase boundary. This implies that during the G2/M phase
of the cell cycle the transcriptional potential of STOX1A is
temporarily lost. We therefore speculate that STOX1A is
necessary for the entry of mitosis but transcriptional activity is
transiently lost during mitosis. This is likely happening in
metaphase and anaphase. During these phases STOX1A is not
bound to DNA. This has also been shown for the forkhead
transcription factor FOXK2 [10] and is in general also found for
most other transcription factors which temporarily lose their
GATCTAGAGAGAATCTGAGCAAATGACAAAGCAAATGGGGTAAAATGTCT
TTTTGTTTAGTTTTTCCTGATTTTCCCATGAGAGGCAAATACATGTTAAG
GATAGTTGAATCTGAGTAAAGGGCATAGAAATATTCCTTACAAGATTTTT
GTTGGCAACTGGTCTAAGTATGAAATTATTTCCAAATAGAAAGCTAAAAC
AAACAAAACAATTGGCCTTGGGAAACTGGACAATCTTGAAGTAATCAAGT
AATATTGTTAAGGGACAATCAGTGTTGTGAAAACAACACGGATACACCCC
CTCCCTCCCCCTCAAAAAAAAAAACCCTAAATTCAGTTCCCCCGTTGCTA
ATGTGTGACCCTGGCAAAGTCATCTAAGTCGCTGAGCTTCAGTTCCTCCA
ACCCAGAGAGTTGTTGCAACGATCAAATGAAAGAATGTCTATTAAAGCCT
TTCATGAACTATATTATTGCTGCTACCGTAGAAATGGAAAGTGTGCAACA
CTAGATCCAAAACTACTTTTGACACTTCTGAGACTGTGGCCGCGCCTCTG
TCACCTTCCAAAGGCCACTAGGCCTTTCCTGAGCTGGCATTGGCAACGCA
CACTCTTGCCCGGCTAACCTTTCCAGGTGGGCGGCGCACTGGCTTCACTG
CTCTCCAGGTGGCCGCTGCAGCTGCCCGAGAGCGCAGGCGCAGAGGCAGA
CCACGTGAGAGCCTGGCCAGGCCTTCCGGCCTAGCCTCACTGTGGCCCCG
CCCCTCTCGAACGCCTTCGCGCGATCGCCCTGGAAACGCATTCTCTGCGA
CCGGCAGCCGCCAATGGGAAGGGAGTGAGTGCCACGAACAGGCCAATAAG
GAGGGAGCAGTGCGGGGTTTAAATCTGAGGCTAGGCTGGCTCTTCTCGGC
start
GTGCTGCGGCGGAACGGCTGTTGGTTTCTGCTGGGTGTAGGTCCTTGGCT
GGTCGGGCCTCCGGTGTTCTGCTTCTCCCCGCTGAGCTGCTGCCTGGTGA
AGAGGAAGCCATGGCGCTCCGAGTCACCAGGGTGAGCCGCTTCGGACTGC
First met
Figure 4. STOX1A binds to the 59 upstream regulatory region of the CCNB1 gene. (A) The DNA sequence previously characterized as the 59
upstream regulatory region of the CCNB1 gene [24,25] indicating the fragment used for quantitative PCR. (B) Chromatin immunoprecipitation was
performed with asynchronized STOX1A stably transfected cells in parallel with STOX1A stably transfected cells synchronized at the G2/M phase
boundary. Significantly higher enrichment for the 59 upstream regulatory region of the CCNB1 gene was found in asynchronized cells compared to
cells synchronized at the G2/M-phase boundary (left vs right bar). Bars are mean 6 SEM, P-values were calculated using two-tailed unpaired t-test. #
indicates P,0.001. (B, left bar). Quantitative PCR results show a mean 75 fold (mean DDCt is 26.23) enrichment for the 59 upstream regulatory region
of the CCNB1 gene in STOX1A stimulated ChIP DNA, compared to their negative controls (ChIP sample vs ChIP negative sample) obtained from
asynchronized STOX1A stably transfected SH-SY5Y cells. (B, right bar) Results show a mean fold 18 (mean DDCt is 24,18), enrichment for the 59
upstream regulatory region of the CCNB1 gene in STOX1A stimulated ChIP DNA, compared to their negative controls (ChIP sample vs ChIP negative
sample) obtained from STOX1A stably transfected SH-SY5Y cells synchronized at the G2/M-phase boundary. Bars are mean 6 SEM. Asterisks indicate
P,0.05 (one sample t-test with theoretical mean 0).
doi:10.1371/journal.pone.0029769.g004
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transcriptional potential during mitosis. This is in contrast to
FoxI1 which continually remains associated with DNA during
mitosis [27]. The translocation of STOX1A away from DNA in
these specific phases during mitosis, thereby losing the potential to
activate or repress target gene transcription, is possibly necessary
for proper mitotic progression or exit.
CCNB1 concentrates at the centrosomes in metaphase during
mitosis [17]. While centrosomes serve as reaction centres for
several key regulators of the cell cycle machinery [14,15], and
several forkhead transcription factors have been shown to
physically interact with the cyclin B1 protein [8–10], we
hypothesize that STOX1A also interacts with the cyclin B1
protein. Indeed, preliminary data using co-immunoprecipitation
suggest this interaction (data not shown). This interaction further
suggests that CDK1, the active binding partner of CCNB1, is
potentially capable of regulating the transcriptional activity of
STOX1A by phosphorylation. Previously, CDK1 has been shown
to phosphorylate FOXM1 [8], FOXO1 [9] and FOXK2 [10]
thereby influencing their activity.
While we studied the effect of STOX1A on CCNB1 in detail, it
is likely that other cell cycle associated proteins are also directly or
indirectly differentially affected by STOX1A. Significant changes
of CCNA2 and CCNC1 mRNA levels upon STOX1A overex-
pression and knockdown, and significant downregulation of
CCNE1 upon STOX1A knockdown suggest that STOX1A is
also involved in regulating other checkpoints of the cell cycle.
As STOX1A is highly expressed in the brain and upregulated in
LOAD makes exploration of STOX1A expression in neuronal
cells in combination with cell cycle events very interesting;
STOX1A might have a role in cell cycle re-entry as observed in
AD.
In conclusion, we show for the first time that STOX1A is
involved in regulating cell cycle events by binding to CCNB1
thereby regulating mitotic entry.
Materials and Methods
Cell culture and transfection
SH-SY5Y human neuroblastoma cells were obtained from the
American Type Culture Collection (ATCC, Manassas, VA). All
reagents for cell culture were purchased from Invitrogen Life
Technologies, Inc. (Burlington, Canada). SH-SY5Y cells were
cultured at 37uC in a humidified atmosphere of 5% CO2 in
Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented
with 10% fetal calf serum and 100 U/ml penicillin, and 100 g/ml
streptomycin. Cells were subcultured in medium every 2–3 days
following harvesting by trypsinization (HBSS containing 5%
trypsin). The ORF (Open Reading Frame) of the STOX1A gene
was subcloned into the pF5K-neomycin CMV Flexi vectors
according to the manufacturers protocol (Promega) and transfect-
ed into SH-SY5Y cells. For transfection the calcium phosphate
method was used [28]. Briefly, at the time of transfection, cells
0          4          8     
Figure 5. Direct upregulation of CCNB1 effectuates enhanced mitotic entry. (A) Stably transfected STOX1A and MOCK SH-SY5Y cells were
synchronized in the S-phase and total cell extracts were prepared from 0, 4 and 8 h after release from the 26thymidine block. Western blotting was
performed using antibodies to Phospho-Histone H3 (Ser 10) and CCNB1. An antibody specific for actin was used as a loading control. Westernblot
image is a representative of at least 3 independent experiments. (B) Westernblot (see 5A) quantification of Phospho-H3 (ser 10) was performed using
densitometry. The ratio number of obtained band intensities for STOX1A divided by actin was compared to the ratio number of obtained band
intensities for MOCK divided by actin for 3 independent experiments. A significant increase for the STOX1A ratio number was found at all time points
compared to the MOCK ratio number. (C) Westernblot (see 5A) quantification of CCNB1 was performed using densitometry. The ratio number of
obtained band intensities for STOX1A divided by actin was compared to the ratio number of obtained band intensities for MOCK divided by actin for
3 independent experiments. A significant increase for the STOX1A ratio number was found at all time points compared to the MOCK ratio number. P-
values were calculated using two-tailed unpaired t-test, error bars represent 6 SEM, * indicate P,0.05, ** indicate P,0.01, *** indicate P,0.001.
doi:10.1371/journal.pone.0029769.g005
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were at 70% confluence. By vortexing 26HEBS (HEPES-buffered
saline) with a solution of 2.5 M CaCl2 and 20 mg of plasmid DNA a
co-precipitate of DNA and CaPO4 was allowed to form. After
incubation for 30 min at room temperature, the precipitate was
added to the cells and the medium was changed after 24 h. For
stable transfections SH-SY5Y cells were transfected either with the
pF5K-STOX1A or empty pF5K constructs. Selection of positive
clones was possible due to the presence of the neomycin resistant
gene present in the constructs. Positive clones were maintained in
complete IMDB medium supplemented with 800 mg/ml G418
(Roche) until reaching confluence and subcultured every 2–3 days
for about 4 weeks. A population of positive clones was harvested for
further analysis. As confirmed with qRT-PCR (See below) using
TaqMan probes (Applied Biosystems) for STOX1A, 3 stable SH-
SY5Y cell-lines with an at least 10 fold STOX1A over-expression
compared to mock transfected cells were selected. Additionally,
plasmid DNA quantification using qPCR (see below) with primers
and probe specific for the constructs backbone showed similar copy
numbers between STOX1A and MOCK transfected cells.
Knockdown of STOX1A was performed by transfecting 4
siRNA’s against STOX1A and control siRNA (Qiagen) in SH-
SY5Y cells with LipofectamineTM RNAiMAX (Invitrogen)
according to the manufactures protocol. Cells were harvested
48 hours post-transfection and RNA was isolated as described in
the Quantitative PCR and RT-PCR section.
Cell proliferation assay in vitro
In each well of a 6-well culture plate 1.56105 untransfected,
STOX1A or MOCK stably transfected SH-SY5Y cells were
seeded. The untransfected cells were transfected with STOX1A
siRNAs (see above). The cell numbers from three wells were
counted every day with a time interval of 24 hours for a total of
72 hours. Viable cells were counted on a CountessH Automated
Cell Counter (Invitrogen) according to the manufactures instruc-
tions. Three independent experiments were performed, and the
means were used to depict the growth curve.
Cell synchronization
Cells were synchronized in an early S-phase by double
thymidine treatment. Briefly, 620% confluent cells were treated
with 2 mM thymidine for 16 h. After being released to normal
growing medium for 8 h, the cells were treated with 2 mM
thymidine for an additional 16 h. Again, after being released to
normal growing medium, cells were harvested or analysed in time
intervals of 2 hours for a total of 8 hours.
For cells to be synchronized at the G2/M-phase boundary, cells
were treated with a thymidine/nocadazole block. Briefly, 640%
confluent cells were treated with 2 mM thymidine for 24 h. After
being released to normal growing medium for 3 h, the cells were
treated with 100 ng/ml nocodazole for 12 h and the cells were
arrested at the G2/M-phase boundary.
Chromatin immunoprecipitation
Stably transfected STOX1A cells (asynchronous or G2/M-
phase boundary arrested) were treated with formaldehyde to
create protein-DNA crosslinks. Cytoplasmic lysis was performed to
reduce competition of cytoplasmic STOX1A-Halotag proteins
against nuclear STOX1A-Halotag proteins with the Halotag resin.
Nuclear lysate was subsequently fragmented by sonication. The
nuclear lysates were split into two equal parts of which one was
treated with Halotag blocking ligand to function as a negative
control. Both the samples and controls were treated using Halotag
resin according to the Halo-ChIP system protocol in the presence
of proteinase inhibitors. After reversal of crosslinks the DNA was
purified using the Qiaquick PCR purification kit (Qiagen).
Quantitative PCR and RT-PCR
Standard quantitative PCR was performed on an ABI7300
(Applied Biosystems) using a probe and primers specific for a fragment
in the 949-bp region previously characterized as the 59 upstream
regulatory region of the CCNB1 gene 24. Probe and primer
characteristics were: CCNB1_foward 59 GTGCGGGGTTTAAA-
TCTGAG 39, CCNB1_reversed 59 CATGGCTTCCTCTTCACC-
AG 39 and 59-FAM 39-TAMRA labeled probe: 59 TGTTCTGCTT-
CTCCCCGCTG 39. Reactions were performed in the presence of
1 M betaine and ROX reference dye, and corrected for input using
the non-intron-spanning Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene expression assay (Applied Biosystems). Input ChIP
DNA was obtained from at least four independent ChIP experiments.
RNA isolation from transfected cells was performed using the
RNeasy kit (Qiagen) including on-column DNase treatment.
Quantitative RT-PCR using gene expression assays (Applied
Biosystems) for CCNA2, CCNB1, CCNC, CCNE1 and STOX1A
were performed on an ABI7300. In addition, transfection effiencies
were corrected by plasmid DNA quantification using the pF5
CMV-neo FlexiH Vector backbone present in all plasmids (pF5
forward: 59-GCTTCGAGCAGACATGATAAG-39, pF5 reversed:
59-AGCAATAGCATCACAAA TTTCA-39, 59-FAM 39-TAMRA
labeled pF5 probe: 59-TGGACAAACCACAACT AGAATGCA-
GT-39). Data were obtained from at least four transfections from
which each RNA sample was measured in triplicate.
Western blot
Protein lysates from transfected cells were obtained by directly
scraping cells into Loading Buffer including b-mercaptoethanol.
Lysates were separated by SDS-polyacrylamide gel electrophore-
sis, and electroblotted onto a PVDF-membrane. An antibody
recognizing endogenous STOX1 (Sigma), Phospho-cdc2 Thr161
(cell signalling) or Phospho-Histone H3 (cell signalling) was used in
combination with goat anti-rabbit horseradish peroxidase-conju-
gated secondary antibody (DAKO). An antibody recognizing
CCNB1 (Millipore) and total cdc2 (clone POH1, cell signalling)
were used in combination with goat anti-mouse IgG horseradish
peroxidase-conjugated secondary antibody (DAKO). Protein
bands were detected by an enhanced-chemiluminescence assay
(GE Healthcare) on a LAS3000.
Immunofluorescence
For immunofluorescence, stably transfected SH-SY5Y cells
were grown on glass coverslips. Coverslips were fixed in 4% (PFA)
paraformaldehyde for 15 min at room temperature. After fixation,
coverslips were rinsed in PBS, 0.1% Triton X-100 and incubated
with 1% Triton X-100 in PBS for 15 min at room temperature for
permeabilization. Coverslips were washed in wash buffer (PBS,
0.1% Triton X-100, 2% BSA (Bovine serum albumin)) blocked
with PBS, 0.1% Triton X-100, 5% BSA for 1 h and incubated
with anti-Halotag (Promega) antibody at 4uC overnight. After
washing with wash buffer, cells were incubated for 1 hour with
anti-rabbit secondary antibodies conjugated with Alexa Fluor 568
(Invitrogen), washed with washing buffer and mounted with
vectashield mounting solution containing DAPI for DNA
counterstaining (Vector Laboratories).
Data analysis
For Real-time PCR data, a threshold cycle number, Ct, was
measured as the PCR cycle at which the amount of amplified
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target reaches the threshold value. Quantification was determined
by the 22DDCt method as described in Applied Biosystems ‘‘Guide
to Performing Relative Quantitation of Gene Expression Using
Real-Time Quantitative PCR’’, Section VII, Relative Quantita-
tion of Gene Expression Experimental Design and Analysis
http://www3.appliedbiosystems.com/cms/groups/mcb_support/
documents/generaldocuments/cms_042380.pdf). Statistical anal-
ysis of the obtained data was carried out with the GraphPad Prism
program.
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